CLS CARES initiative mobilizes over 50 volunteers to pack nearly 14,000 meals for seniors in need HOUSTON, TEXAS / ACCESS ...

AUSTIN, TEXAS / ACCESS Newswire / May 19, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands and ...

BEIJING, CHINA / ACCESS Newswire / May 19, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...

MiscellaneousFormycon and Fresenius Kabi announce FDA Approval of Interchangeability for FYB202/Otulfi® (ustekinumab-aauz) 19.05.2025 / 15:00 CET/CESTThe issuer is solely responsible for the content ...

Early results show steroid-free remission, opening pathway into $13B global pet dental health marketVELDONA delivers consistent anti-inflammatory effects, strengthening Ainos' positioning in companion ...

Company reports quarterly revenue of $1.4 million; net loss and earnings per diluted Share of $6.6 million and $1.74Quarterly adjusted EBITDA loss of $2.5 million reflects 29% YOY ...

YUMA, AZ / ACCESS Newswire / May 19, 2025 / Onvida Health, a leading provider of integrated care throughout Arizona, and Ambience Healthcare, the leading AI platform for clinical documentation, CDI, ...

New international rankings spotlight 30 urban health hubs across 57 countries eliminating medical data silos, optimizing electronic records, and setting the pace for cross-sector interoperability NEW ...

Emsculpt NEO is now available at BODYWELLE to assist with physical recovery, muscle balance, and functional strength. MIAMI BEACH, FLORIDA / ACCESS Newswire / May 19, 2025 / Emsculpt Neo, already ...

ULTRA Through 24 Hour Fitness Locations Nationwide.Strategic Partnership Brings Innovation to Fitness Channel with First-of-its-Kind In-Gym Activation MONROE, CT / ACCESS Newswire / May 19, 2025 / GAT ...

IRVINE, CA / ACCESS Newswire / May 19, 2025 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of deep venous disease, ...

Co-founded by Landmark BioVentures and researchers from Aix-Marseille University, Massalia will develop its sole-in-class therapeutic platform targeting conditions interlinking challenging diseases: ...